Remedent Stock Price Patterns
| REMI Stock | USD 0.0007 0.00 0.00% |
Momentum 91
Buy Peaked
Oversold | Overbought |
Using Remedent hype-based prediction, you can estimate the value of Remedent from the perspective of Remedent response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Remedent to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Remedent because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Remedent after-hype prediction price | USD 9.55E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Remedent |
Remedent After-Hype Price Density Analysis
As far as predicting the price of Remedent at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Remedent or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Remedent, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Remedent Estimiated After-Hype Price Volatility
In the context of predicting Remedent's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Remedent's historical news coverage. Remedent's after-hype downside and upside margins for the prediction period are 0.00 and 10.28, respectively. We have considered Remedent's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Remedent is out of control at this time. Analysis and calculation of next after-hype price of Remedent is based on 3 months time horizon.
Remedent Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Remedent is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Remedent backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Remedent, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.74 | 10.28 | 0.02 | 0.00 | 7 Events / Month | 1 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0007 | 0.001 | 36.50 |
|
Remedent Hype Timeline
Remedent is at this time traded for 0.0007. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.0. Remedent is expected to increase in value after the next headline, with the price projected to jump to 9.55E-4 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is estimated to be 36.5%, whereas the daily expected return is at this time at 1.74%. The volatility of related hype on Remedent is about 1.2336E7%, with the expected price after the next announcement by competition of 0.00. Remedent currently holds 9.43 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Remedent has a current ratio of 1.8, which is within standard range for the sector. Debt can assist Remedent until it has trouble settling it off, either with new capital or with free cash flow. So, Remedent's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Remedent sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Remedent to invest in growth at high rates of return. When we think about Remedent's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Remedent Basic Forecasting Models to cross-verify your projections.Remedent Related Hype Analysis
Having access to credible news sources related to Remedent's direct competition is more important than ever and may enhance your ability to predict Remedent's future price movements. Getting to know how Remedent's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Remedent may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SECI | Sector 10 | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SDCCQ | SmileDirectClub | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OLMM | OneLife Technologies Corp | 0.00 | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIAP | Via Pharmaceuticals | 0.00 | 7 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XSNX | NovAccess Global | 0.00 | 0 per month | 0.00 | 0.08 | 0.00 | 0.00 | 480.00 | |
| EVLO | Evelo Biosciences | (0.0005) | 7 per month | 0.00 | 0.05 | 0.00 | (50.00) | 460.00 |
Remedent Additional Predictive Modules
Most predictive techniques to examine Remedent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Remedent using various technical indicators. When you analyze Remedent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Remedent Predictive Indicators
The successful prediction of Remedent stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Remedent, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Remedent based on analysis of Remedent hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Remedent's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Remedent's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for Remedent Pink Sheet analysis
When running Remedent's price analysis, check to measure Remedent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Remedent is operating at the current time. Most of Remedent's value examination focuses on studying past and present price action to predict the probability of Remedent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Remedent's price. Additionally, you may evaluate how the addition of Remedent to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |